Werbung
Werbung

BHC

BHC logo

Bausch Health Companies Inc

7.42
USD
Gesponsert
-0.35
-4.57%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

7.43

+0.01
+0.19%

BHC Ergebnisberichte

Positives Überraschungsverhältnis

BHC übertreffen die 22 der letzten 40Schätzungen.

55%

Nächster Bericht

Datum des nächsten Berichts
17. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.74B
/
$1.29
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+2.04%
/
+12.17%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+6.91%
/
+13.16%

Bausch Health Companies Inc earnings per share and revenue

On 29. Okt. 2025, BHC reported earnings of 1.15 USD per share (EPS) for Q3 25, beating the estimate of 1.13 USD, resulting in a 2.59% surprise. Revenue reached 2.68 milliarde, compared to an expected 2.66 milliarde, with a 0.65% difference. The market reacted with a +12.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of 1.29 USD, with revenue projected to reach 2.74 milliarde USD, implying an increase of 12.17% EPS, and increase of 2.04% in Revenue from the last quarter.
FAQ
For Q3 2025, Bausch Health Companies Inc reported EPS of $1.15, beating estimates by 2.59%, and revenue of $2.68B, 0.65% above expectations.
The stock price moved up 12.03%, changed from $5.90 before the earnings release to $6.61 the day after.
The next earning report is scheduled for 17. Feb. 2026.
Based on 5 analysts, Bausch Health Companies Inc is expected to report EPS of $1.29 and revenue of $2.74B for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung